[ad_1]
▶ Click here to enlarge the view
Shinseonmi = On the 27th, the second day of the national vaccination against the new coronavirus infection (Corona 19), the Pfizer vaccine will also be launched after the AstraZeneca (AZ) product.
The AstraZeneca vaccine was started the day before for residents and workers under the age of 65 in nursing hospitals and nursing facilities, and the Pfizer vaccine will be administered to medical staff to treat COVID-19 patients starting that day.
The first medical staff to receive the Pfizer vaccine are approximately 55,000 people from 143 hospitals to treat COVID-19 patients, including hospitals dedicated to infectious diseases and hospitals to treat seriously ill patients, and 35 live treatment centers. This means that vaccination for medical personnel who are at the forefront of the Corona 19 response will be in full swing.
According to the Korea Centers for Disease Control and Prevention, 300 medical staff members will receive the Corona 19 vaccine at the Central Vaccination Center of the National Medical Center in Jung-gu, Seoul. There are 199 workers at the National Medical Center and 101 workers at the treatment hospital for COVID-19 patients in the metropolitan area.
The vaccines that fit are part of the initial volume of 58,000 people (117,000 doses) introduced through the COVAX facility, an international vaccine supply organization.
The vaccine arrived at Incheon International Airport on a Korean Air flight A330-300 at 11:58 am the day before. The Pfizer vaccine delivered in temperature-controlled containers was subdivided into individual container units at the airport’s cargo terminal, divided into five transportation vehicles, and delivered to five vaccination centers across the country.
▶ Click here to enlarge the view
Pfizer’s vaccine is an mRNA (messenger ribonucleic acid) vaccine, which must maintain a temperature of around -75 degrees below zero during distribution and storage, and requires pre-treatment such as thawing and dilution before use.
Consequently, vaccination begins first in an inoculation center that can systematically manage the entire process and then expands to each medical institution.
Regarding specific vaccination locations and times, vaccinations are carried out from this day until the 12th of the following month at the central vaccination center of the central medical center. It is a three-day consecutive holiday from that day through March 1, but the vaccine is given normally and the vaccine is not given on the following weekends and holidays, March 6-7.
Vaccines are administered from the 3rd to the 9th of the following month at three regional vaccination centers, including Soonchunhyang University Cheonan Hospital, Yangsan Busan National University Hospital, Chosun University Hospital, and Daegu Hospital. Dongsan University of Keimyung, a regional vaccination center.
Starting on the 8th of next month, the government plans to deliver the Pfizer vaccines from the vaccination center to 82 medical institutions, so that they can receive their own vaccines according to institutional plans.
The central center will deliver the vaccine to each medical institution from the 8th to the 16th of the following month, and the regional center from the 10th to the 16th of the following month.
The medical institutions receiving the vaccine must complete the vaccination before the 20th of the following month. Among the medical personnel of each medical institution, the list of people who will go to the vaccination center and receive their own vaccination at the institution was confirmed the day before.
The government plans to finish the first vaccination for the 55,000 medical staff treating COVID-19 patients by the 20th of next month, and the second vaccination will begin on March 20, three weeks later, and will end on April 10.
Meanwhile, national health centers and nursing hospitals continue to receive the AstraZeneca vaccine for a second day.
Among the AstraZeneca vaccine targets, 289,000 people accepted the actual vaccination starting on day 25. The consent rate for vaccination is high, 93.7%.
[연합뉴스]
Copyright ⓒ Yonhap News. Unauthorized reproduction and redistribution prohibited